Autoantigen‐specific regulatory T cells, a potential tool for immune‐tolerance reconstitution in type‐2 autoimmune hepatitis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24039PMID 21274874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct Roles for CCR4 and CXCR3 in the Recruitment and Positioning of Regulatory T Cells in the Inflamed Human Liver

  2010cited by this paper
• Naturally Arising Human CD4 T-Cells That Recognize Islet Autoantigens and Secrete Interleukin-10 Regulate Proinflammatory T-Cell Responses via Linked Suppression

  2010cited by this paper
• GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.

  2009cited by this paper
• Curing CNS autoimmune disease with myelin‐reactive Foxp3+ Treg

  2009cited by this paper
• Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

  2009cited by this paper
• Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients1

  2009cited by this paper
• T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

  2009cited by this paper
• Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

  2008cited by this paper
• Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis

  2008cited by this paper
• Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2

  2007cited by this paper
• Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis

  2006cited by this paper
• The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells

  2006cited by this paper
• Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

  2006cited by this paper
• Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

  2006cited by this paper
• Multiplex mapping of CD4 T cell epitopes using class II tetramers.

  2006cited by this paper
• Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis1

  2006cited by this paper
• Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells.

  2006cited by this paper
• Functional avidity directs T-cell fate in autoreactive CD4+ T cells.

  2005cited by this paper
• Tolerogenic Semimature Dendritic Cells Suppress Experimental Autoimmune Thyroiditis by Activation of Thyroglobulin-Specific CD4+CD25+ T Cells1

  2005influential reference
• CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.

  2005cited by this paper
• Mature dendritic cells differentiated in the presence of interferon‐b and interleukin‐3 prime functional antigen‐specific CD8+ T cells

  2005cited by this paper
• Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.

  2005cited by this paper
• Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• T Cells , Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide , Suppress Autoimmune Diabetes

  2004cited by this paper
• In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

  2004cited by this paper
• Cytochrome P4502D6193–212: A New Immunodominant Epitope and Target of Virus/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease 1

  2003cited by this paper
• Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity

  2002cited by this paper
• Intramolecular epitope spreading among anti‐caspase‐8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals

  2002cited by this paper
• Increase of chemokine interferon‐inducible protein‐10 (IP‐10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes

  2001cited by this paper
• Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes1

  2001cited by this paper
• MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

  1999cited by this paper
• Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

  1989cited by this paper

• Role of cell-based therapies in digestive disorders: Obstacles and opportunities

  2025cites this paper
• Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead

  2025cites this paper
• Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

  2025cites this paper
• Unmet needs in autoimmune liver diseases.

  2025cites this paper
• Can we cure autoimmune hepatitis?

  2025cites this paper
• B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.

  2024cites this paper
• Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy.

  2024cites this paper
• Antigen-specific T cells and autoimmunity.

  2024cites this paper
• Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis

  2022cites this paper
• Pathogenesis of Autoimmune Hepatitis—Cellular and Molecular Mechanisms

  2021cites this paper
• Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies

  2021cites this paper
• A reasoned approach to the treatment of autoimmune hepatitis.

  2021cites this paper
• Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications

  2021cites this paper
• Regulatory T cells in autoimmune hepatitis: Un updated overview.

  2021cites this paper
• Established and novel therapeutic options for autoimmune hepatitis.

  2021cites this paper
• Cellular therapies for the treatment of immune-mediated GI and liver disease.

  2020cites this paper
• Autoimmune Hepatitis

  2020cites this paper
• Hepatitis

  2020cites this paper
• The Pathogenesis of Liver Diseases in Pregnancy

  2020cites this paper
• Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease

  2020cites this paper
• Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients

  2020cites this paper
• Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.

  2020cites this paper
• Type 2 Autoimmune Hepatitis in a Male Patient with a Rare Complication of Vasculitis

  2020cites this paper
• Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis.

  2019cites this paper
• Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.

  2019cites this paper
• Autoimmune hepatitis in the pediatric age

  2019cites this paper
• Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection

  2019cites this paper
• Diffuse Systemic Sclerosis in a Patient with Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome: A Case Report

  2019cites this paper
• Role of regulatory T cells in pathogenesis and therapy of autoimmune liver disease

  2019cites this paper
• Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis

  2019cites this paper
• Novel therapeutic targets in autoimmune hepatitis.

  2018cites this paper
• Cellular and Molecular Mechanisms of Autoimmune Hepatitis.

  2018cites this paper
• Autoimmune Hepatitis in Children.

  2018cites this paper
• Morbid Sequences Suggest Molecular Mimicry between Microbial Peptides and Self-Antigens: A Possibility of Inciting Autoimmunity

  2017cites this paper
• Novel Immunotherapies for Autoimmune Hepatitis

  2017cites this paper
• Recurrent Disease Following Liver Transplantation

  2017cites this paper
• EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani.

  2017cites this paper
• Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells

  2017cites this paper
• [Autoimmune hepatitis in the pediatric age].

  2017cites this paper
• Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association

  2017cites this paper
• Hepatitis autoinmune en la edad pediátrica

  2017cites this paper
• Autoimmune hepatitis: From mechanisms to therapy.

  2016cites this paper
• 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.

  2016cites this paper
• Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives

  2016cites this paper
• Diego and Giorgina Vergani: The two hearts of translational autoimmunity.

  2016cites this paper
•  Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.

  2016cites this paper
• Examination of Centrilobular Necrosis in Autoimmune Hepatitis using Bayesian Networks

  2016cites this paper
• DYSFUNCTIONAL CD39 REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS Short title: CD39 REGULATORY T CELLS IN AUTOIMMUNE HEPATITIS

  2016cites this paper
• Auto immune hepatitis.

  2016cites this paper
• Contemporary issues and future directions in autoimmune hepatitis

  2016cites this paper
• Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease

  2015cites this paper
• Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis

  2015cites this paper
• Paediatric Autoimmune Liver Disease

  2015cites this paper
• Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications

  2015cites this paper
• Chapter 1 An update of Auto Immune Hepatitis : epidemiology , clinical aspects and treatment Submitted

  2015cites this paper
• A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation

  2015cites this paper
• Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases

  2015cites this paper
• Adoptive cell transfer in autoimmune hepatitis

  2015cites this paper
• Autoimmune hepatitis: an approach to disease understanding and management.

  2015cites this paper
• Autoimmune hepatitis

  2015cites this paper
• The importance of liver microcirculation in promoting autoimmune hepatitis via maintaining an inflammatory cytokine milieu--a mathematical model study.

  2014cites this paper
• Chapter 61 – Hepatitis

  2014cites this paper
• Hepatitis autoinmune en niños. Perspectivas actuales

  2014cites this paper
• [Autoimmune hepatitis in children: current perspectives].

  2014cites this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Dysfunctional CD39 Regulatory T Cells and Aberrant Control of T-Helper Type 17 Cells in Autoimmune Hepatitis

  2014cites this paper
• Future Perspective: Immunomodulatory Therapy for Autoimmune Hepatitis

  2014cites this paper
• Humoral Immune Mechanism of Liver Injury in Giant Cell Hepatitis With Autoimmune Hemolytic Anemia

  2014cites this paper
• CYP2E1 autoantibodies in liver diseases

  2014cites this paper
• Autoimmune hepatitis in children: Progression of 20 cases in northern Mexico

  2014cites this paper
• Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2.

  2014cites this paper
• Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets

  2014cites this paper
• Autoimmune hepatitis in children: progression of 20 cases in northern Mexico.

  2014cites this paper
• Juvenile autoimmune hepatitis: Spectrum of the disease.

  2014cites this paper
• Review article: autoimmune hepatitis – current management and challenges

  2013cites this paper
• Mucosal immunity in liver autoimmunity: a comprehensive review.

  2013cites this paper
• Autoimmune Hepatitis: A Review on Disease Pathology and Novel Vitamin D-Associated Disease Progression

  2013cites this paper
• Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury

  2013cites this paper
• Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ.

  2013cites this paper
• Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review.

  2013cites this paper
• Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance

  2013cites this paper
• Regulatory T-cell directed therapies in liver diseases.

  2013cites this paper
• Autoimmune hepatitis: a comprehensive review.

  2013cites this paper
• The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.

  2013cites this paper
• Autoimmune hepatitis.

  2013cites this paper
• Treatment of autoimmune liver disease: current and future therapeutic options

  2013cites this paper
• article : autoimmune hepatitis – current management and challenges

  2013cites this paper
• Review article: overlap syndromes and autoimmune liver disease

  2012cites this paper
• Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?

  2012cites this paper
• Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.

  2012cites this paper
• Cell therapies for liver diseases

  2012cites this paper
• Over-expression of Hlx homeobox gene in DC2.4 dendritic cell enhances its maturation and antigen presentation.

  2012cites this paper
• The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin‐9/tim‐3 pathway

  2012cites this paper
• A clear look at the neuroimmunology of multiple sclerosis and beyond.

  2012cites this paper
• Effectors and regulators of cellular immune response in autoimmune liver disease

  2012cites this paper
• Cutting Edge Issues in Autoimmune Hepatitis

  2012cites this paper
• Management of patients with difficult autoimmune hepatitis

  2012cites this paper
• Epatite Autoimmune: una terapia non sempre facile

  2012cites this paper
• Current world literature.

  2012cites this paper
• Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

  2012cites this paper
• Autoimmune hepatitis in children: an overview of the disease focusing on current therapies

  2012cites this paper